Optimization of Pharmaceutical R&D Programs and Portfolios

Optimization of Pharmaceutical R&D Programs and Portfolios

Design and Investment Strategy

Antonijevic, Zoran

Springer International Publishing AG

08/2016

202

Mole

Inglês

9783319343129

15 a 20 dias

3285

Descrição não disponível.
Need for Optimal Design of Pharmaceutical Programs and Portfolios in Modern Medical Product Development.- Clinical Aspects of Pharmaceutical Portfolio Management.- Drug Development and the Cost of Capital.- Investment Considerations for Pharmaceutical Product Portfolios.- Challenges of Portfolio Management in Pharmaceutical Development.- Impact of Phase 2b Strategies on Optimization of Drug Development Programs.- Using Decision Analysis to Support the Design of Clinical Trials at a Program Level.- Indication Sequencing for a New Molecular Entity with Multiple Potential Oncology Indications.- Maximizing Return on Investment in Phase II Proof-of-Concept Trials.- Portfolio Optimization of Therapies and Their Predictive Biomarkers.- Dynamically Optimizing Budget Allocation for Phase 3 Drug Development Portfolios Incorporating Uncertainty in the Pipeline.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Decision Analysis;Decision Making;Optimization;Pharmaceutical Portfolio;Portfolio Optimization;Quantitative Methods